Manhattan Scientifics (MHTX) Financial Statements

26 Followers

Manhattan Scientifics Financial Overview

Manhattan Scientifics's market cap is currently $55.93K. The company's EPS TTM is $-0.0008; its P/E ratio is -0.05; Manhattan Scientifics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 50.00K	$ 50.00K	$ 50.00K	$ 97.00K
Gross Profit	$ -1.00K	$ 50.00K	$ 50.00K	$ 50.00K	$ 97.00K
Operating Income	$ -703.00K	$ -679.00K	$ -687.00K	$ -675.00K	$ -1.02M
EBITDA	$ -1.16M	$ -2.71M	$ -3.61M	$ 4.34M	$ -1.22M
Net Income	$ -1.17M	$ -2.73M	$ -3.64M	$ 4.31M	$ -1.22M
Balance Sheet
Cash & Short-Term Investments	$ 67.00K	$ 175.00K	$ 232.00K	$ 353.00K	$ 261.00K
Total Assets	$ 316.00K	$ 1.03M	$ 3.45M	$ 6.85M	$ 2.23M
Total Debt	$ 60.00K	$ 110.00K	$ 130.00K	$ 104.00K	$ 78.00K
Net Debt	$ -7.00K	$ -65.00K	$ -102.00K	$ -249.00K	$ -183.00K
Total Liabilities	$ 2.12M	$ 2.73M	$ 2.42M	$ 2.17M	$ 3.23M
Stockholders' Equity	$ -1.80M	$ -1.70M	$ 1.03M	$ 4.67M	$ -1.00M
Cash Flow
Free Cash Flow	$ -190.00K	$ -349.00K	$ -421.00K	$ -392.00K	$ -316.00K
Operating Cash Flow	$ -190.00K	$ -349.00K	$ -421.00K	$ -388.00K	$ -316.00K
Investing Cash Flow	$ 102.00K	$ 332.00K	$ 300.00K	$ 480.00K	$ 340.00K
Financing Cash Flow	$ -20.00K	$ -40.00K	$ 0.00	$ 24.00K	$ 150.00K

Currency in USD

Manhattan Scientifics Earnings and Revenue History

Income Statement >

Manhattan Scientifics Debt to Assets

Balance Sheet >

Manhattan Scientifics Cash Flow

Cash Flow >

Manhattan Scientifics Forecast EPS vs Actual EPS

Earnings >